NMT1 and B-cell non-Hodgkin lymphoma: All these studies provide supporting evidence that miR-99 is a critical player in cancer pathogenesis, which is possibly derived from post-transcriptional regulation of NMT. Study by Schramedei et al. demonstrated that MetAP2 is a putative target of miR-21 in B-cell lymphomas [173].